Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma− Heading towards a promising change in treatment paradigm
U Mahmood, E Carrier, K Khan - Cancer Treatment Reviews, 2024 - Elsevier
Traditional chemotherapy-based adjuvant therapies for locally advanced pancreatic ductal
adenocarcinoma (PDAC) have been associated with poor clinical outcomes driven partly by …
adenocarcinoma (PDAC) have been associated with poor clinical outcomes driven partly by …
Radiogenomic analysis for predicting lymph node metastasis and molecular annotation of radiomic features in pancreatic cancer
Y Tang, Y Su, J Zheng, M Zhuo, Q Qian, Q Shen… - Journal of Translational …, 2024 - Springer
Background To provide a preoperative prediction model for lymph node metastasis in
pancreatic cancer patients and provide molecular information of key radiomic features …
pancreatic cancer patients and provide molecular information of key radiomic features …
CLEAR guideline for radiomics: Early insights into current reporting practices endorsed by EuSoMII
Purpose This study aims to evaluate current reporting practices in radiomics research, with a
focus on CheckList for EvaluAtion of Radiomics research (CLEAR). Methods We conducted …
focus on CheckList for EvaluAtion of Radiomics research (CLEAR). Methods We conducted …
[HTML][HTML] Multiomics-Based Outcome Prediction in Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR)
Simple Summary Each patient responds uniquely to treatment, which makes personalized
ultra-fractionated stereotactic adaptive radiotherapy (PULSAR) a promising strategy that …
ultra-fractionated stereotactic adaptive radiotherapy (PULSAR) a promising strategy that …
Multiomics-based Outcome Prediction for the Treatment of Brain Metastases with Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy (PULSAR)
H Zhang, M Dohopolski, S Stojadinovic… - arXiv preprint arXiv …, 2024 - arxiv.org
Purpose: We aimed to develop a data-driven multiomics approach integrating radiomics,
dosiomics, and delta features to predict treatment response at an earlier stage (intra …
dosiomics, and delta features to predict treatment response at an earlier stage (intra …
Prediction of the benign and malignant nature of masses in COPD background based on Habitat-based enhanced CT radiomics modeling: A preliminary study
W Zuo, J Li, M Zuo, M Li, S Zhou… - Technology and Health …, 2024 - content.iospress.com
BACKGROUND: It is difficult to differentiate between chronic obstructive pulmonary disease
(COPD)-peripheral bronchogenic carcinoma (COPD-PBC) and inflammatory masses …
(COPD)-peripheral bronchogenic carcinoma (COPD-PBC) and inflammatory masses …